These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21309766)

  • 1. Treating inflammation in childhood neurodegenerative disorders.
    Lim M
    Dev Med Child Neurol; 2011 Apr; 53(4):298-304. PubMed ID: 21309766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse models of human neurodegenerative disorders: requirements for medication development.
    Bloom FE; Reilly JF; Redwine JM; Wu CC; Young WG; Morrison JH
    Arch Neurol; 2005 Feb; 62(2):185-7. PubMed ID: 15710845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation, neurodegenerative diseases, and environmental exposures.
    Campbell A
    Ann N Y Acad Sci; 2004 Dec; 1035():117-32. PubMed ID: 15681804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target.
    Kaminska B; Gozdz A; Zawadzka M; Ellert-Miklaszewska A; Lipko M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1902-13. PubMed ID: 19943344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and Parkinson's disease pathogenesis.
    Przedborski S
    Mov Disord; 2010; 25 Suppl 1():S55-7. PubMed ID: 20187228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection from complement-mediated inflammatory damage.
    Kulkarni AP; Kellaway LA; Lahiri DK; Kotwal GJ
    Ann N Y Acad Sci; 2004 Dec; 1035():147-64. PubMed ID: 15681806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral vectors as tools to model and treat neurodegenerative disorders.
    Déglon N; Hantraye P
    J Gene Med; 2005 May; 7(5):530-9. PubMed ID: 15651039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw.
    Spires TL; Hannan AJ
    FEBS J; 2005 May; 272(10):2347-61. PubMed ID: 15885086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects for gene therapy in inherited neurodegenerative diseases.
    Cardone M
    Curr Opin Neurol; 2007 Apr; 20(2):151-8. PubMed ID: 17351484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic dissection of neurodegeneration and CNS inflammation.
    Olsson T; Piehl F; Swanberg M; Lidman O
    J Neurol Sci; 2005 Jun; 233(1-2):99-108. PubMed ID: 15894332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interplay between inflammation and neurodegeneration in CNS disease.
    Esiri MM
    J Neuroimmunol; 2007 Mar; 184(1-2):4-16. PubMed ID: 17187866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs: novel therapeutic targets in neurodegenerative diseases.
    Roshan R; Ghosh T; Scaria V; Pillai B
    Drug Discov Today; 2009 Dec; 14(23-24):1123-9. PubMed ID: 19822222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?
    Marchetti B; Abbracchio MP
    Trends Pharmacol Sci; 2005 Oct; 26(10):517-25. PubMed ID: 16126283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation in central nervous system injury.
    Allan SM; Rothwell NJ
    Philos Trans R Soc Lond B Biol Sci; 2003 Oct; 358(1438):1669-77. PubMed ID: 14561325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditionally inducible tau mice--designing a better mouse model of neurodegenerative diseases.
    Janus C
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():12-27. PubMed ID: 18184367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonviral siRNA delivery for gene silencing in neurodegenerative diseases.
    Prakash S; Malhotra M; Rengaswamy V
    Methods Mol Biol; 2010; 623():211-29. PubMed ID: 20217554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate and adaptive immune activation in the brain of MPS IIIB mouse model.
    DiRosario J; Divers E; Wang C; Etter J; Charrier A; Jukkola P; Auer H; Best V; Newsom DL; McCarty DM; Fu H
    J Neurosci Res; 2009 Mar; 87(4):978-90. PubMed ID: 18951493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic gene therapy for a neurodegenerative disease using microencapsulated recombinant cells.
    Ross CJ; Ralph M; Chang PL
    Exp Neurol; 2000 Dec; 166(2):276-86. PubMed ID: 11085893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear receptors, inflammation, and neurodegenerative diseases.
    Saijo K; Crotti A; Glass CK
    Adv Immunol; 2010; 106():21-59. PubMed ID: 20728023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.